Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ALTH

<< Previous 18 19 20 21 22 23 24 25 26 27 28

Date	Time	Source	Headline	Symbol	Company
24/05/2004	22:13	PR Newswire (US)	Geller Rudman Announces Class Action Lawsuit Against Allos Therapeutics, Inc. on Behalf of Investors	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
24/05/2004	21:13	PR Newswire (US)	Shareholder Class Action Filed Against Allos Therapeutics, Inc. by the Law Firm of Schiffrin & Barroway, LLP	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
21/05/2004	23:00	PR Newswire (US)	Weinstein Kitchenoff Scarlato Karon & Goldman Ltd. Announces Class Action Lawsuit Against Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
06/05/2004	12:00	PR Newswire (US)	Allos Therapeutics Reports First Quarter 2004 Financial Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
04/05/2004	23:25	PR Newswire (US)	Allos Therapeutics to Hold Q1 2004 Financial Results Conference Call and Webcast on Thursday, May 6	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
03/05/2004	23:04	PR Newswire (US)	FDA Advisory Committee Does Not Recommend Approval of RSR13 as Adjunctive Therapy for the Treatment of Brain Metastases Originat	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
30/04/2004	22:30	PR Newswire (US)	Allos to Discuss ODAC Panel Recommendation on Monday May 3, 2004	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
12/03/2004	19:54	PR Newswire (US)	Allos NDA to be Reviewed by FDA Advisory Committee	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
11/03/2004	20:17	PR Newswire (US)	American Stock Exchange to Trade Options on Three Securities	NASDAQ:ALTH
05/03/2004	23:59	PR Newswire (US)	Allos Therapeutics Files Shelf Registration Statement	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
12/02/2004	12:45	PR Newswire (US)	Reminder - Allos Therapeutics Management Conference Call	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
12/02/2004	12:00	PR Newswire (US)	Allos Begins Phase 3 Study of RSR13 in Women With Brain Metastases From Breast Cancer	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
12/02/2004	11:00	PR Newswire (US)	Allos Therapeutics Reports Fourth Quarter and Year-End 2003 Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
04/12/2003	11:00	PR Newswire (US)	Allos Completes New Drug Application for Novel Treatment for Patients With Breast Cancer and Brain Metastases	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
03/12/2003	22:30	PR Newswire (US)	Arizona Cancer Center Investigator Presents Positive Survival and Quality of Life Data From RSR13 Phase 3 Study	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
24/11/2003	12:00	PR Newswire (US)	Allos Therapeutics Announces RSR13 Phase 3 Results in Patients With Breast Cancer and Brain Metastases Will Be Highlighted at th	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/11/2003	22:24	PR Newswire (US)	Allos Therapeutics Completes $12 Million Private Placement	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
18/11/2003	17:30	PR Newswire (US)	Allos Therapeutics Announces Presentation of Phase 1 Results of PDX in Patients With Advanced Non-Small Cell Lung Cancer	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
17/11/2003	11:00	PR Newswire (US)	Allos Therapeutics Announces Presentation of RSR13 Phase 3 Results in Brain Metastases at the Eighth Annual Meeting of the Socie	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
15/11/2003	19:00	PR Newswire (US)	RSR13 Investigator Presented With National Tumor Foundation Research Award At Society for Neuro-Oncology Annual Meeting	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
06/11/2003	12:45	PR Newswire (US)	Reminder - Webcast Alert: Allos Therapeutics, Inc. Announces Third Quarter 2003 Financial Results Conference Call on the Web	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
06/11/2003	11:00	PR Newswire (US)	Allos Therapeutics Reports Third Quarter 2003 Financial Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
31/10/2003	12:45	PR Newswire (US)	Webcast Alert: Allos Therapeutics, Inc. Announces Third Quarter 2003 Financial Results Conference Call on the Web	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)